Physician profile
Na Li
NPI 1780918615
$843.49
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $196 · 2023: $42.68 · 2024: $19.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $62.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $62.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.22 | 2019-2020 | |
| Lilly USA, LLC | $103.00 | 2019-2020 | |
| Amgen INC. | $96.86 | 2019-2020 | |
| Glaxosmithkline, LLC. | $78.00 | 2019-2020 | |
| Pfizer INC. | $75.62 | 2020-2024 | |
| Novo Nordisk INC | $67.95 | 2019 | |
| Novartis Pharmaceuticals Corporation | $52.97 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $34.75 | 2019 | |
| Radius Health, INC. | $28.62 | 2019 | |
| Astellas Pharma US INC | $23.80 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $21.88 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $20.73 | 2020 | |
| Alexion Pharmaceuticals, INC. | $20.37 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $17.93 | 2020 | |
| Allergan, INC. | $15.93 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.89 | 2020 | |
| Ironwood Pharmaceuticals, INC | $14.64 | 2019 | |
| Sanofi Pasteur INC. | $14.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Na Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.